Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo

OBJECTIVE: Carcinosarcoma is a deadly gynecologic malignancy with few effective treatment options. The study of new therapies is difficult because of its rarity. The objective of this study was to determine the efficacy of neratinib in the treatment of HER2 amplified carcinosarcoma. METHODS: The eff...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Gynecol Oncol
Huvudupphovsmän: Schwab, Carlton L., English, Diana P., Black, Jonathan, Bellone, Stefania, Lopez, Salvatore, Cocco, Emiliano, Bonazzoli, Elena, Bussi, Beatrice, Predolini, Federica, Ferrari, Francesca, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas, Schwartz, Peter E., Santin, Alessandro D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587290/
https://ncbi.nlm.nih.gov/pubmed/26260909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2015.08.002
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk